Barr's Duramed Pharmaceuticals announces acceptance of its NDA submission for the low-dose version of its extended-cycle contraceptive Feb. 25. Lo Seasonique (levonorgestrel/ethinyl estradiol), which has an Oct. 24 action date, combines two trends in oral contraceptives - low-dose formulations and extended-cycle use to limit the number of withdrawal bleeds. Barr's Seasonale already has generic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Low-dose Seasonique NDA accepted
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account